EUVIMEDEUVIMED entdecken
Open Access

Death receptors regulate entry to therapy-induced senescence and orchestrate addiction to IAPs

Gokhan Gunay iD, Seren Hamsici iD, Vaishnavi Venugopalan iD, Aoife Costigan, Melanie Fritsch iD, Aislinn Gallagher Aldave, Anne Huber, Brianna Fernandez, Hande Efe-Cicek, Pavel Davidovich iD, Pavitha Parathan iD, Akash Srivaths und 10 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aed4541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Gokhan Gunay und 21 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cell Biology Laboratory, Dept. of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland. Hauptthemen laut MEDLINE: Cellular Senescence, Receptors, TNF-Related Apoptosis-Inducing Ligand, Inhibitor of Apoptosis Proteins, Receptors, Death Domain. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytotoxic chemotherapy typically results in the elimination of a fraction of the tumor with surviving cells entering a state of persistence or premature replicative senescence that can lead to recurrence. Here, we show that therapy-induced senescence is associated with robust up-regulation of Fas and/or TRAIL-R2/DR5 death receptors in vitro and in vivo. The latter receptors restricted entry to senescence and exerted selective pressure on senescent cells through promoting assembly of proapoptotic receptor-interacting protein kinase 1 (RIPK1)/Fas-associated death domain protein (FADD)/Caspase-8 “FADDosome” complexes, restrained by cFLIP L . Accordingly, deletion of CASP-8 robustly enhanced entry to senescence and prolonged the life span of senescent cells. cIAP-2, which inhibits death receptor–driven cell death, was also up-regulated in senescent cells, and deletion of IAPs suppressed entry to senescence. Consistent with this, small-molecule IAP antagonists exhibited potent senolytic activity through enhancing death receptor–initiated Caspase-8 activation. Thus, death receptor–driven assembly of RIPK1/FADD/Caspase-8 complexes in senescent cells orchestrates addiction to IAPs that can be exploited by IAP antagonists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceReceptors, TNF-Related Apoptosis-Inducing LigandInhibitor of Apoptosis ProteinsReceptors, Death DomainHumansCaspase 8Fas-Associated Death Domain ProteinAnimalsReceptor-Interacting Protein Serine-Threonine Kinasesfas ReceptorApoptosisMiceCASP8 and FADD-Like Apoptosis Regulating ProteinCell Line, Tumor

Substanzen

Caspase 8Fas-Associated Death Domain ProteinReceptors, TNF-Related Apoptosis-Inducing LigandInhibitor of Apoptosis ProteinsReceptor-Interacting Protein Serine-Threonine KinasesRIPK1 protein, humanfas ReceptorCASP8 and FADD-Like Apoptosis Regulating ProteinReceptors, Death DomainFADD protein, human

Autor:innen und Institutionen

  • Molecular Cell Biology Laboratory, Dept. of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland.
  • Institute for Molecular Immunology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
  • School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia.
  • BioFrontiers Institute, University of Colorado, Boulder, CO 80303, USA.
  • La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3086 Australia.

ORCID-Profile: Gokhan Gunay, Seren Hamsici, Vaishnavi Venugopalan, Melanie Fritsch, Pavel Davidovich, Pavitha Parathan, Eleanor Noone, Jeffrey O'Callaghan, Lisa A Mielke, Sarah L Doyle, Sabrina L Spencer, Matthew Campbell, Hamid Kashkar, Seamus J Martin

Förderung

  • NCI NIH HHS
  • NIA NIH HHS
  • NIGMS NIH HHS
  • European Research Council
  • Irish Research Council
  • NIH Director’s New Innovator Award
  • Research Ireland

Zitieren

APA

Gunay, G., Hamsici, S., Venugopalan, V., Costigan, A., Fritsch, M., Gallagher Aldave, A., Huber, A., Fernandez, B., Efe-Cicek, H., Davidovich, P., Parathan, P., Srivaths, A., Hudson, N., Noone, E., O'Callaghan, J., Mielke, L. A., Doyle, S. L., Spencer, S. L., Campbell, M., …, & Martin, S. J. (2026). Death receptors regulate entry to therapy-induced senescence and orchestrate addiction to IAPs. Science Advances. https://doi.org/10.1126/sciadv.aed4541

Vancouver

Gunay G, Hamsici S, Venugopalan V, Costigan A, Fritsch M, Gallagher Aldave A, et al. Death receptors regulate entry to therapy-induced senescence and orchestrate addiction to IAPs. Science Advances. 2026. doi:10.1126/sciadv.aed4541

BibTeX
@article{Gunay2026,
  author = {Gunay, Gokhan and Hamsici, Seren and Venugopalan, Vaishnavi and Costigan, Aoife and Fritsch, Melanie and Gallagher Aldave, Aislinn and Huber, Anne and Fernandez, Brianna and Efe-Cicek, Hande and Davidovich, Pavel and Parathan, Pavitha and Srivaths, Akash and Hudson, Natalie and Noone, Eleanor and O'Callaghan, Jeffrey and Mielke, Lisa A and Doyle, Sarah L and Spencer, Sabrina L and Campbell, Matthew and Kearney, Conor J and Kashkar, Hamid and Martin, Seamus J},
  title = {Death receptors regulate entry to therapy-induced senescence and orchestrate addiction to IAPs},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aed4541}
}
Kostenlos starten →